Bristol-Myers Squibb Company Ce
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Bristol-Myers Squibb Company Ce's balance sheet done over the years? Its assets were worth $95,159,000,000 last year, which is less than in the previous period. 69% of Bristol-Myers Squibb Company Ce’s total assets is currently financed by debt. Its liabilities reached the amount of $65,674,000,000, which means an decrease by 0% compared compared to last year.
Debt to Assets
| 2014 | 33749000000 | 18.76B | 55.6% |
|---|---|---|---|
| 2015 | 31748000000 | 17.32B | 54.57% |
| 2016 | 33707000000 | 17.36B | 51.5% |
| 2017 | 33551000000 | 21.70B | 64.69% |
| 2018 | 10659000000 | 7.34B | 68.95% |
| 2019 | 129944000000 | 78.24B | 60.22% |
| 2020 | 118481000000 | 80.59B | 68.03% |
| 2021 | 109314000000 | 73.30B | 67.06% |
| 2022 | 96820000000 | 65.70B | 67.86% |
| 2023 | 95159000000 | 65.67B | 69.02% |
CELG-RI Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 11.46B | 9.12B | 13.97B | 14.54B | 12.34B | 6.91B | 5.42B | 4.23B | 2.38B | 5.57B |
Short term investments | 816M | 130M | 3.24B | 1.28B | 3.04B | 1.97B | 1.39B | 2.11B | 1.88B | 1.86B |
Net receivables | 15.26B | 13.93B | 12.51B | 8.50B | 7.68B | 5.96B | 6.3B | 5.54B | 4.29B | 3.39B |
Inventory | 2.66B | 2.33B | 2.09B | 2.07B | 4.29B | 1.19B | 1.16B | 1.24B | 1.22B | 1.56B |
Other current assets | 1.56B | 1.59B | 1.29B | 1.36B | 1.98B | 1.11B | 576M | 2.68B | 625M | 2.22B |
Total current assets | 31.77B | 27.27B | 33.26B | 30.19B | 29.35B | 8.88B | 14.85B | 13.70B | 10.41B | 14.60B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 8.03B | 7.47B | 6.96B | 6.74B | 6.25B | 5.02B | 5.00B | 4.98B | 4.41B | 4.41B |
Goodwill | 21.16B | 21.14B | 20.50B | 20.54B | 22.48B | 6.53B | 6.86B | 6.87B | 6.88B | 7.02B |
Intangible assets | 27.07B | 36.35B | 42.77B | 53.24B | 63.96B | 1.09B | 1.21B | 1.38B | 1.41B | 1.75B |
Long term investments | 2.49B | 2.18B | 2.71B | 4.50B | 767M | 1.77B | 2.48B | 2.71B | 4.66B | 4.40B |
Other non-current assets | 1.84B | 1.03B | 1.65B | 2.08B | 6.60B | -14.02B | 1.53B | 1.04B | 1.11B | 621M |
Total non-current assets | 63.38B | 69.54B | 76.05B | 88.28B | 100.59B | 1.77B | 18.69B | 20.00B | 21.33B | 19.14B |
Total assets | 95.15B | 96.82B | 109.31B | 118.48B | 129.94B | 10.65B | 33.55B | 33.70B | 31.74B | 33.74B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 271M | 1.34B | 3.69B | 3.62B | 4.49B | 172M | 83M | 762M | 1.00B | 1.16B |
Short term debt | 3.28B | 4.4B | 5.11B | 2.50B | 3.47B | 1.70B | 987M | 992M | 139M | 590M |
Total current liabilities | 22.26B | 21.89B | 21.86B | 19.08B | 18.30B | 1.70B | 9.56B | 8.84B | 8.01B | 8.46B |
| Non-current liabilities: | ||||||||||
Long term debt | 38.18B | 36.31B | 40.47B | 49.16B | 44.05B | 5.64B | 6.97B | 5.71B | 6.55B | 7.24B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 4.59B | 5.04B | 6.13B | 6.58B | 9.00B | 4.09B | 4.71B | 2.25B | 2.17B | 2.29B |
Total non-current liabilities | 43.41B | 43.81B | 51.44B | 61.51B | 59.94B | 5.64B | 12.14B | 8.51B | 9.30B | 10.30B |
Total liabilities | 65.67B | 65.70B | 73.30B | 80.59B | 78.24B | 7.34B | 21.70B | 17.36B | 17.32B | 18.76B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |